McCarthy Sean A.

Avg. Two Year Performance

No purchase track record
42% Avg. Sale Return
19% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return4%3%3%11%42%
Sale Success Rate9 of 179 of 178 of 1710 of 1713 of 17

Cytomx Therapeutics, Inc.

Other » Other

CEO, Director:

Holdings: 727.41K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--